Assertio

Search

Overview

Recent News

Date	Title and Summary
Toggle Summary Nov 10, 2020	Assertio to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020 LAKE FOREST, Ill. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings , Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that President, chief executive officer and director, Todd Smith will present at and participate in investor meetings at
Toggle Summary Nov 06, 2020	Assertio Reports Third Quarter 2020 Financial Results Reported Net Product Sales of $34.3 Million Non-GAAP Net Product Sales of $33.7 Million ; Increased 21.4% over Pro-Forma Second Quarter 2020 Non-GAAP Net Product Sales Consistent with Pro-Forma Prior Year Quarter Despite COVID-19 Related Sales Disruptions and Effects of Sales Force Integration
Toggle Summary Oct 23, 2020	Assertio to Release Third Quarter 2020 Financial Results and Host Webcast on November 6, 2020 LAKE FOREST, Ill. , Oct. 23, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, today announced that its third quarter 2020 financial results will be released on Friday, November 6, 2020 .

Recent SEC Filings

Filing date	Description	Form	Filing Group	View
Apr 18, 1997	Optional form for the registration of securities to be sold to the public by small business issuers	SB-2	Registration Statements	View HTML 0001012870-97-000776.pdf 0001012870-97-000776.rtf 0001012870-97-000776.xls
Jun 17, 1997	Pre-effective amendment to an SB-2 filing	SB-2/A	Registration Statements	View HTML 0001012870-97-001176.pdf 0001012870-97-001176.rtf 0001012870-97-001176.xls
Jun 17, 1997	Registration of certain classes of securities 12(b) of the Securities Exchange Act	8-A12B	Registration Statements	View HTML 0001012870-97-001177.pdf 0001012870-97-001177.rtf 0001012870-97-001177.xls
Jun 27, 1997	Substantive changes from or additions to a prospectus previously filed	424A	Registration Statements	View HTML 0000940180-97-000582.pdf 0000940180-97-000582.rtf 0000940180-97-000582.xls
Aug 01, 1997	Pre-effective amendment to an SB-2 filing	SB-2/A	Registration Statements	View HTML 0001012870-97-001374.pdf 0001012870-97-001374.rtf 0001012870-97-001374.xls

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA

Investor Relations Contact

investor@assertiotx.com